Literature DB >> 20458444

miR-20a promotes proliferation and invasion by targeting APP in human ovarian cancer cells.

Xingxing Fan1, Yankun Liu, Jiechun Jiang, Zhuoya Ma, Haidong Wu, Tao Liu, Min Liu, Xin Li, Hua Tang.   

Abstract

MicroRNAs (miRNAs) are emerging as a class of small regulated RNAs, and the alterations of miRNAs are implicated in the initiation and progression of human cancers. Our study shows that inhibition of miR-20a in OVCAR3 ovarian cancer cell line could suppress, whereas overexpression of miR-20a could enhance cell long-term proliferation and invasion. We also confirmed amyloid precursor protein (APP) as a direct target gene of miR- 20a. Furthermore, suppression of APP expression could also promote ovarian cancer cell proliferation and invasion, which is consistent with the results of miR-20a overexpression. Therefore, we concluded that the regulation of APP is an important mechanism for miR-20a to promote proliferation and invasion in ovarian cancer cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20458444     DOI: 10.1093/abbs/gmq026

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  35 in total

1.  MicroRNA-101 downregulates Alzheimer's amyloid-β precursor protein levels in human cell cultures and is differentially expressed.

Authors:  Justin M Long; Debomoy K Lahiri
Journal:  Biochem Biophys Res Commun       Date:  2010-12-21       Impact factor: 3.575

2.  MicroRNA-153 physiologically inhibits expression of amyloid-β precursor protein in cultured human fetal brain cells and is dysregulated in a subset of Alzheimer disease patients.

Authors:  Justin M Long; Balmiki Ray; Debomoy K Lahiri
Journal:  J Biol Chem       Date:  2012-06-25       Impact factor: 5.157

3.  Metastasis-suppressor transcript destabilization through TARBP2 binding of mRNA hairpins.

Authors:  Hani Goodarzi; Steven Zhang; Colin G Buss; Lisa Fish; Saeed Tavazoie; Sohail F Tavazoie
Journal:  Nature       Date:  2014-07-09       Impact factor: 49.962

Review 4.  MicroRNAs: a connection between cholesterol metabolism and neurodegeneration.

Authors:  Leigh Goedeke; Carlos Fernández-Hernando
Journal:  Neurobiol Dis       Date:  2014-06-05       Impact factor: 5.996

Review 5.  Advances in microRNA experimental approaches to study physiological regulation of gene products implicated in CNS disorders.

Authors:  Justin M Long; Debomoy K Lahiri
Journal:  Exp Neurol       Date:  2012-01-05       Impact factor: 5.330

6.  MicroRNA-339-5p down-regulates protein expression of β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) in human primary brain cultures and is reduced in brain tissue specimens of Alzheimer disease subjects.

Authors:  Justin M Long; Balmiki Ray; Debomoy K Lahiri
Journal:  J Biol Chem       Date:  2013-12-18       Impact factor: 5.157

7.  TGFβR2 is a major target of miR-93 in nasopharyngeal carcinoma aggressiveness.

Authors:  Xiaoming Lyu; Weiyi Fang; Longmei Cai; Hang Zheng; Yanfen Ye; Lan Zhang; Jinbang Li; Hong Peng; William C S Cho; Ena Wang; Francesco M Marincola; Kaitai Yao; Hongbing Cai; Jiliang Li; Xin Li
Journal:  Mol Cancer       Date:  2014-03-08       Impact factor: 27.401

8.  MicroRNA-20a contributes to cisplatin-resistance and migration of OVCAR3 ovarian cancer cell line.

Authors:  Yankun Liu; Sugui Han; Yuhui Li; Yan Liu; Di Zhang; Yufeng Li; Jinghua Zhang
Journal:  Oncol Lett       Date:  2017-06-08       Impact factor: 2.967

9.  Ovarian tumor-associated microRNA-20a decreases natural killer cell cytotoxicity by downregulating MICA/B expression.

Authors:  Jingyan Xie; Mengna Liu; Yujuan Li; Yunzhong Nie; Qiongyu Mi; Shuli Zhao
Journal:  Cell Mol Immunol       Date:  2014-05-12       Impact factor: 11.530

10.  miR-20a enhances cisplatin resistance of human gastric cancer cell line by targeting NFKBIB.

Authors:  Yiping Du; Mingxia Zhu; Xin Zhou; Zebo Huang; Jun Zhu; Jing Xu; Gongming Cheng; Yongqian Shu; Ping Liu; Wei Zhu; Tongshan Wang
Journal:  Tumour Biol       Date:  2015-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.